Intensive care unit management of intra-abdominal infection.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 12973184)

Published in Crit Care Med on August 01, 2003

Authors

John C Marshall1, Marilyn Innes

Author Affiliations

1: Department of Surgery, University of Toronto and Toronto General Hospital, University Health Network, Ontario, Canada. John.Marshall@uhn.on.ca

Associated clinical trials:

Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury (SAD) | NCT01355094

Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume | NCT01911702

Articles citing this

Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med (2013) 4.37

Mechanisms of mortality in early and late sepsis. Infect Immun (2006) 1.88

A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. BMC Infect Dis (2005) 1.40

A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J Immunol (2011) 1.36

Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Crit Care (2012) 1.16

Natural orifice transluminal endoscopic surgery (NOTES) as a diagnostic tool in the intensive care unit. Surg Endosc (2007) 1.14

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci (2010) 1.13

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis (2010) 1.06

Management of peritonitis in the critically ill patient. Surg Clin North Am (2006) 1.03

Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria. Eur J Med Res (2010) 0.91

Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit Care (2010) 0.91

Bedside diagnostic laparoscopy in the intensive care unit: a 13-year experience. JSLS (2006) 0.90

Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care (2010) 0.90

Deferred primary anastomosis versus diversion in patients with severe secondary peritonitis managed with staged laparotomies. World J Surg (2010) 0.88

[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87

Diffuse postoperative peritonitis -- value of diagnostic parameters and impact of early indication for relaparotomy. Eur J Med Res (2009) 0.85

Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking. PLoS Pathog (2009) 0.85

Leptin and leptin receptor polymorphisms are associated with poor outcome (death) in patients with non-appendicular secondary peritonitis. Crit Care (2011) 0.85

Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis. Clin Vaccine Immunol (2007) 0.85

Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol (2010) 0.83

Current and future concepts of abdominal sepsis. World J Surg (2005) 0.83

Infectiological diagnostic problems in tertiary peritonitis. Langenbecks Arch Surg (2006) 0.82

Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis. Langenbecks Arch Surg (2008) 0.82

A Comprehensive review of abdominal infections. World J Emerg Surg (2011) 0.81

Primary bacteraemia is associated with a higher mortality risk compared with pulmonary and intra-abdominal infections in patients with sepsis: a prospective observational cohort study. BMJ Open (2015) 0.81

Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis. World J Surg (2009) 0.80

Systemic Inflammatory Response during Laparotomy. Int J Inflam (2014) 0.79

Etiology, treatment outcome and prognostic factors among patients with secondary peritonitis at Bugando Medical Centre, Mwanza, Tanzania. World J Emerg Surg (2015) 0.78

A peritonitis model with low mortality and persisting intra-abdominal abscesses. Int J Exp Pathol (2006) 0.77

A decision rule to aid selection of patients with abdominal sepsis requiring a relaparotomy. BMC Surg (2013) 0.77

Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol (2009) 0.76

Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection. Ann Surg Treat Res (2015) 0.75

Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes. BMC Infect Dis (2015) 0.75

Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model. Int J Colorectal Dis (2006) 0.75

Articles by these authors

How well does the Parkland formula estimate actual fluid resuscitation volumes? J Burn Care Rehabil (2002) 1.17